and get paid for it.” Regardless of Altman’s company facing criticism over copyright infringement concerns and ethical debates surrounding its AI models, the company continues to push ...

company developing targeted cancer therapies using its proprietary RADR® AI platform, today announced that the first patient has been enrolled and dosed in Taiwan for its Phase 2 HARMONIC ...

Type C FDA consultation for phase 2 trial design has completed ... About Merry Life Biomedical Company Merry Life Biomedical is a Taiwan-based biotechnology company focused on developing ...

TAIPEI and SAN DIEGO, Nov. 9, 2023 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing ... been successfully dosed in Taiwan Phase II Study of Silmitasertib ...